» Articles » PMID: 19238283

Spectral Relative Standard Deviation: a Practical Benchmark in Metabolomics

Overview
Journal Analyst
Specialty Chemistry
Date 2009 Feb 25
PMID 19238283
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolomics datasets, by definition, comprise of measurements of large numbers of metabolites. Both technical (analytical) and biological factors will induce variation within these measurements that is not consistent across all metabolites. Consequently, criteria are required to assess the reproducibility of metabolomics datasets that are derived from all the detected metabolites. Here we calculate spectrum-wide relative standard deviations (RSDs; also termed coefficient of variation, CV) for ten metabolomics datasets, spanning a variety of sample types from mammals, fish, invertebrates and a cell line, and display them succinctly as boxplots. We demonstrate multiple applications of spectral RSDs for characterising technical as well as inter-individual biological variation: for optimising metabolite extractions, comparing analytical techniques, investigating matrix effects, and comparing biofluids and tissue extracts from single and multiple species for optimising experimental design. Technical variation within metabolomics datasets, recorded using one- and two-dimensional NMR and mass spectrometry, ranges from 1.6 to 20.6% (reported as the median spectral RSD). Inter-individual biological variation is typically larger, ranging from as low as 7.2% for tissue extracts from laboratory-housed rats to 58.4% for fish plasma. In addition, for some of the datasets we confirm that the spectral RSD values are largely invariant across different spectral processing methods, such as baseline correction, normalisation and binning resolution. In conclusion, we propose spectral RSDs and their median values contained herein as practical benchmarks for metabolomics studies.

Citing Articles

Rapid microcystin-LR detection using antibody-based electrochemical biosensors with a simplified calibration curve approach.

Adjei-Nimoh S, Rances L, Tony M, Nabwey H, Lee W Sci Rep. 2024; 14(1):31968.

PMID: 39738474 PMC: 11685771. DOI: 10.1038/s41598-024-83623-w.


Selected Ion Monitoring for Orbitrap-Based Metabolomics.

Lu W, McBride M, Lee W, Xing X, Xu X, Li X Metabolites. 2024; 14(4).

PMID: 38668312 PMC: 11051813. DOI: 10.3390/metabo14040184.


Nickel and cobalt-based tungstate nanocomposites as promising electrocatalysts in alkaline direct methanol fuel cells.

Mahmoud I, Farghali A, El-Rouby W, Abdelwahab A Nanoscale Adv. 2024; 6(8):2059-2074.

PMID: 38633046 PMC: 11019479. DOI: 10.1039/d3na01118f.


Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice.

Viant M, Amstalden E, Athersuch T, Bouhifd M, Camuzeaux S, Crizer D Arch Toxicol. 2024; 98(4):1111-1123.

PMID: 38368582 PMC: 10944399. DOI: 10.1007/s00204-024-03680-y.


Plasma metabolomics supports non-fasted sampling for metabolic profiling across a spectrum of glucose tolerance in the Nile rat model for type 2 diabetes.

Anderson B, Curtis A, Jen A, Thomson J, Clegg D, Jiang P Lab Anim (NY). 2023; 52(11):269-277.

PMID: 37857753 PMC: 10611569. DOI: 10.1038/s41684-023-01268-0.